News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
606 Results
Type
Article (25)
Company Profile (1)
Press Release (580)
Section
Business (119)
Deals (15)
Drug Development (180)
FDA (8)
Job Trends (6)
News (330)
Policy (31)
Tag
Academia (1)
Alliances (27)
Approvals (7)
Best Places to Work (3)
Biotechnology (1)
Cell therapy (2)
Clinical research (148)
Collaboration (1)
COVID-19 (5)
C-suite (1)
Data (13)
Diagnostics (3)
Earnings (75)
Events (64)
FDA (10)
Funding (3)
Government (1)
Healthcare (8)
HIV (1)
Indications (1)
Infectious disease (20)
Influenza (9)
IPO (7)
Job creations (3)
Legal (1)
Manufacturing (2)
Mergers & acquisitions (8)
NextGen: Class of 2026 (5)
Non-profit (1)
Opinion (1)
People (26)
Phase 1 (39)
Phase 2 (76)
Phase 3 (42)
Pipeline (15)
Postmarket research (5)
Preclinical (33)
Regulatory (31)
Research institute (1)
RSV (2)
Series B (1)
Startups (3)
Vaccines (23)
Date
Last 30 days (1)
Last 365 days (35)
2026 (3)
2025 (36)
2024 (56)
2023 (16)
2022 (30)
2021 (20)
2020 (20)
2019 (10)
2018 (15)
2017 (38)
2016 (28)
2015 (38)
2014 (39)
2013 (55)
2012 (50)
2011 (46)
2010 (31)
Location
Africa (3)
Asia (17)
Australia (3)
California (9)
Canada (1)
China (1)
Connecticut (16)
Europe (54)
Florida (2)
Maryland (3)
Massachusetts (2)
Michigan (1)
Nevada (1)
New Jersey (21)
New York (10)
Northern California (6)
Pennsylvania (4)
South America (1)
Southern California (3)
United States (72)
Utah (2)
Washington State (3)
606 Results for "clade therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
July 15, 2025
·
10 min read
Press Releases
Applied DNA Launches Mpox Clade I and Clade II Testing Service
September 11, 2024
·
3 min read
Deals
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.
October 2, 2023
·
4 min read
Press Releases
Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1
September 9, 2024
·
3 min read
Press Releases
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
September 5, 2024
·
4 min read
Press Releases
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 23, 2024
·
3 min read
Press Releases
Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 19, 2024
·
3 min read
Deals
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Century Therapeutics announced plans to expand clinical development for its lead program, CNTY-101, a CD19-targeting iNK cell therapy, into additional autoimmune disease indications.
April 11, 2024
·
13 min read
Business
Clade and GRObio Land Series A Funds for Cancer, Protein Therapeutics
Clade Therapeutics will use its funds to further its research and development on cancer treatments, while GRO Biosciences will focus on chronic diseases.
November 3, 2021
·
2 min read
·
Vanessa Doctor, RN
Infectious disease
Mid-Stage Study Finds Only Mpox Drug Ineffective Against Current Outbreak
SIGA Technologies’ TPOXX did not outperform placebo at resolving lesions in patients with clade I mpox, the new strain that has spread through parts of Africa and is reaching beyond the continent.
August 19, 2024
·
2 min read
·
Tristan Manalac
1 of 61
Next
